Screening outcome following EVH
| Gender | Age (year) | BMI (kg·m-2) | Audible sign | FeNO (ppb) | EVH (% fall in FEV1) | EIA |
| M | 55 | 24 | Inspiratory stridor | 37* | −1.6 | Negative |
| F | 50 | 24 | Inspiratory stridor | 18 | −5.3 | Negative |
| F | 38 | 25 | Inspiratory stridor | 18 | −3.7 | Negative |
| F | 24 | 22 | Stridor+wheeze | 31* | −25.1† | Positive |
| M | 26 | 27 | Stridor+wheeze | 19 | −4.2 | Negative |
| F | 21 | 23 | Stridor+wheeze | 17 | −1.4 | Negative |
| F | 59 | 24 | Cough | 15 | −5.5 | Negative |
| F | 46 | 29 | Cough | 16 | −6.0 | Negative |
| M | 25 | 28 | Cough | 19 | −8.3 | Negative |
| F | 36 | 24 | Cough | 40* | −0.5 | Negative |
*FeNO ≥25 ppb (intermediate).
†EIA ≥15% fall in FEV1.
BMI, body mass index; EIA, exercise-induced asthma; EVH, eucapnic voluntary hyperpnoea; FeNO, fractional exhaled nitric oxide.